Form 4: Cardlytics Director Srishti A. Gupta Acquires 11,000 Restricted Stock Units

Director Srishti A. Gupta acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.

Summary

• On May 20, 2025, Srishti A. Gupta, a director of Cardlytics, Inc. (CDLX), acquired 11,000 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Cardlytics common stock or its cash equivalent, at the Issuer's election.
• The RSUs will vest in full on the one-year anniversary of the grant date, provided Gupta remains a director of Cardlytics on that date.
• Following the transaction, Gupta beneficially owns 11,000 shares of common stock through the RSUs.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects an insider's investment in the company, suggesting confidence. However, it's a routine transaction.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the RSUs is contingent on the director's continued service, aligning their interests with the company's long-term success.

Industry Context

Form 4 filings are standard disclosures for corporate insiders and provide transparency into their transactions in the company's securities.

Stakeholder Impact

• The acquisition of RSUs by a director can positively influence shareholder sentiment.

Key Dates

Keywords

Cardlytics, Director, Srishti A. Gupta, Restricted Stock Units, RSU, Beneficial Ownership, Form 4, CDLX, Equity Securities, Vesting